Xenon Pharmaceuticals Inc. (XENE) Capital expenditures 2016–2025
Xenon Pharmaceuticals Inc. (XENE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$799,000FY2025 · since FY2016: $279,000 → $799,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $799,000 | -74.0% |
| FY2024 | $3.1M | -45.3% |
| FY2023 | $5.6M | +94.1% |
| FY2022 | $2.9M | +41.2% |
| FY2021 | $2.0M | -22.3% |
| FY2020 | $2.6M | +112.7% |
| FY2019 | $1.2M | +144.6% |
| FY2018 | $507,000 | +61.0% |
| FY2017 | $315,000 | +12.9% |
| FY2016 | $279,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice